• Explore /
  • Poster
  • / Randomized phase II study comparing neoadjuvant FLOT versus DOS for patients with type 4 or large type 3 gastric cancer (JCOG2204).

Randomized phase II study comparing neoadjuvant FLOT versus DOS for patients with type 4 or large type 3 gastric cancer (JCOG2204).

Abstract Poster

Authors

null

Izuma Nakayama

The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto-Ku, Japan

Izuma Nakayama , Manabu Ohashi , Junki Mizusawa , Hiroshi Kawachi , Tadayoshi Hashimoto , Ryosuke Kita , Yukinori Kurokawa , Narikazu Boku , Masanori Terashima , Haruhiko Fukuda , Takaki Yoshikawa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Small Bowel Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

jRCTs031230231

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr TPS418)

DOI

10.1200/JCO.2024.42.3_suppl.TPS418

Abstract #

TPS418

Poster Bd #

N3

Abstract Disclosures

Similar Posters

First Author: Yung-Jue Bang

First Author: Claudia Pauligk

First Author: Claudia Pauligk

First Author: Yelena Y. Janjigian